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ABSTRACT
After pulse exposure to concentrations of actinomycin D (AMD) sufficient to abolish tran-
scription, Vero cells recover RNA synthesis much more rapidly than most other cell types .
This is only in part attributable to the remarkable capacity of Vero very promptly to excrete
bound AMD, elimination of which, although necessary, is not a sufficient condition for re-
surgence of RNA synthesis. After elimination of higher concentrations of AMD from Vero,
although over-all RNA synthesis resumes a normal rate within 24 hr, protein synthesis lags,
and a long period of division-delay ensues . Division-delay lasting 2-3 days results from expo-
sure of Vero to doses of AMD greater than those that suppress RNA synthesis by greater
than 90% (e.g. 1 µg/ml for 2 hr) but not by lower doses, which permit almost immediate
reentry into the cell cycle. In contrast, although L cells recover over-all RNA synthesis very
slowly after pulse treatment with AMD, resumption of protein synthesis or cell division is not
comparably delayed thereafter . These and other data suggest that the early restoration of
RNA synthesis in Vero after relief of inhibition by AMD is qualitatively imperfect . The
results reported herein are explainable by the hypothesis that the synthesis of those species of
RNA which are involved, directly or indirectly, in reactivating the transcription of genes
controlling progression in the cell cycle is relatively resistant to suppression by AMD . Decay
of such RNA templates and their products, which differs in different cell types during inhibi-
tion by AMD, determines the duration of division-delay.
INTRODUCTION
The suppression of RNA synthesis for some hours
by actinomycin D (AMD), or by anthracyclines,
results in irreparable damage in most cell lines,
manifested either acutely or after one or more days
(1). Although transcription is virtually suppressed
by moderate concentrations of AMD (I ug/ml),
Vero cells are remarkably more resistant to cyto-
intoxication than are other cell types, even by
much higher doses (e.g. 10-50 µg/ml) (1, 2) . In
contrast to other cell lines (e.g. HeLa, L, W138,
WIL2, MDBK), Vero are capable of resuming
RNA synthesis very rapidly after withdrawal of
AMD (1, 2), an observation since verified in other
laboratories (3, 4) . We had also indicated that
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Vero can eliminate or excrete bound AMD very
rapidly, faster than do other cell lines (1, 2) . In this
communication we report the results of experi-
ments on the binding and release of AMD in rela-
tion to RNA synthesis, and the relation of recovery
of transcription to protein synthesis and cell divi-
sion. It will be shown that elimination of drug,
although a necessary antecedent of recovery, is not
per se a sufficient condition for restoration of tran-
scription, and the apparent prompt recovery of
over-all RNA synthesis in Vero is not followed by
commensurate restoration of protein synthesis, or
cell division.
299MATERIALS AND METHODS
The cells and their maintenance have been described
previously (I). Monolayer cultures of HeLa, Vero,
and L cells were maintained in a growth medium con-
sisting of Eagle's minimal essential medium (Auto-
Pow MEM, Flow Laboratories, Rockville, Md .)
supplemented with newborn or fetal calf serum (10%
v/v), MEM nonessential amino acids, streptomycin
(75 µg/ml), and penicillin (75 units/ml) (Grand
Island Biological Co., Grand Island, N.Y.), and in an
atmosphere of 57 0 CO2. The cells were kept in expo-
nential growth by passage twice or thrice weekly.
Doubling times of HeLa, Vero, and L cells were 19
hr, 21 hr, and 17 hr, respectively . Once a month the
cultures were grown for 2 days in the presence of
Tylocine (Anti-PPLO Agent, Grand Island Biologi-
cal Co.), 50 µg/ml of aureomycin or 20 µg/ml of
chloramphenicol; periodic tests for mycoplasma
were always negative. Experiments were performed
on cells explanted to 35 mm diameter Petri dishes
(Falcon Plastics, Division of B-D Laboratories, Inc.,
Los Angeles, Calif.) 1 or 2 days before beginning
the experiments when the cell number per dish was
between 0.7 and 1 .2 X 106.
Actinomycin D (Merck Sharp & Dohme, West
Point, Pa.) was dissolved in dimethyl sulfoxide, di-
luted in saline, and sterile filtered . Since AMD binds
to nitrocellulose filters, the exact concentration of the
AMD stock solution was determined by measuring the
optical density of 441 nm (E = 25.7 X 103) after
filtration. Direct exposure to light of solutions contain-
ing AMD and of cells treated with AMD was avoided .
The stock solution was diluted with fresh growth
medium to the desired drug concentration and ad-
ministered in a volume of 2 ml/10 6 cells. After re-
moval of AMD, the cells were rinsed once with
balanced saline and refed with fresh drug-free growth
medium; the cells were refed again 3-5 hr later to
remove the AMD that had diffused back into the
medium, and every day thereafter .
RNA and protein syntheses were measured by
determining the amount of uridine- 14C (50.5-58
mCi/mmole, New England Nuclear Corp ., Boston,
Mass. or Schwarz Bio Research, Orangeburg, N.Y.)
and amino acids- 14C (1 .5 mCi/mg, New England
Nuclear Corp.), respectively, incorporated during a
given period of time into the cold acid-insoluble (5%
trichloroacetic acid, [TCA]) cellular material . The
uridine-14C was diluted to 0.1-0.3 µCi/ml (2-6 X
10-6 M uridine) with fresh growth medium containing
2 X 10-5 M deoxycytidine and thymidine to prevent
incorporation of the label into DNA. The amino acids-
"C were diluted to 1 µCi/ml with fresh growth
medium that had one tenth the normal concentration
of MEM amino acids and did not contain MEM
nonessential amino acids. The labels were adminis-
tered in a volume of 1 ml per 35-mm Petri dish. After
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incubation of the cells in the label for the times speci-
fied in the Results section of this article, the medium
containing label was removed by suction and the cells
were rinsed thrice with balanced saline which con-
tained 5 X 10-4 M uridine or MEM amino acids and
the cells were detached by incubation for 3 min in I
ml of 0.25% trypsin-0.15% Versene in balanced
saline. After dispersion of the cells, a sample of a
known number of cells was solubilized with Soluene-
100 (Packard Instrument Co., Inc., Downers Grove,
Ill.), or was precipitated and washed with ice cold 5%
TCA. The acid-insoluble precipitates were either
collected on membrane filters (Bac-T-Flex, B-6,
Schleicher & Schuell Inc., Keene, N.H.) or solubi-
lized with Soluene- 100. The samples were counted in a
toluene base scintillant (Omnifluor, Pilot Chemicals,
Inc., Watertown, Mass .) with a Packard Liquid
Scintillation Spectrometer . The counting efficiency
was determined using either a channel ratios method
or an automatic external standard ; the counting effi-
ciency varied between 78% and 82%. Greater than
94% of the radioactivity associated with the acid-
precipitable material during a 1 hr labeling period
with uridine-14C was hydrolyzed with 0.3 N KOH at
37°C for 18 hr; and the rate of incorporation of radio-
labeled uridine is linear for at least 2 hr at the concen-
trations of uridine used .
The binding of AMD-14C (11 .4 mCi/mmole, New
England Nuclear Corp.) by cells has been described
previously (1). Briefly, dilutions of AMD-14C were
administered to the cells, and at specified times the
label was removed, the cells were rinsed thrice with
balanced saline, and refed with fresh drug-free growth
medium. The cells were trypsinized and collected for
scintillation counting as described above . Radio-
autography of cell cultures treated with AMD- 3H (8.4
Ci/mmole ; Schwarz Bio Research) showed the label
to be associated only with the nucleus and removable
by heating the cells to 98°C for 10 min in 4% form-
aldehyde buffered at pH 7.0.
Morphological examination and mitotic indices
were performed on cells grown on cover glasses and
fixed in cold methanol, acetic acid, Formalin
(85:5 :10), and stained with azure and eosin.
RESULTS
Recovery of RNA Synthesis after AMD
Vero cells begin to recover their capacity to in-
corporate radiolabeled uridine into acid-precipi-
table material within 2-3 hr after removal of 10
µg/ml of AMD after having been exposed to the
drug for 1 or 4 hr ; in contrast, L cells treated for 1
hr with 5 µg/ml begin to reestablish RNA synthe-
sis only after a much longer interval (9-12 hr) and at
a much slower rate (Fig. 1). Thus, Vero cells can
restore RNA synthesis much more promptly after5
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FIGURE 1 Recovery of RNA synthesis after treatment
with AMD. Vero cells were exposed to 10 µg/ml of
AMD in the presence of uridine-14C (0.2 µCi/ml,
4 µCi/nnnole) for 1 hr (/) or for 4 hr (UI), and L cells
to 5 µg/ml of AMD for 1 hr (Y), after which times the
AMD was removed and the cells were rinsed and refed
with fresh drug-free medium containing the above
concentration of uridine-14C. At the points indicated
on the graph, duplicate sets of cells were prepared for
liquid scintillation spectrometry as described in Mate-
rials and Methods. El, untreated Vero; V, untreated L
cells. The slope of lines cannot be used to compare the
exact rates of RNA synthesis after recovery from AMD
in this experiment because of the smaller intracellular
pool of nucleotides in the control as compared to the
AMD-treated cells (see text) .
removal of AMD than other types of animal cells in
culture, even though Vero have been treated for
longer periods and with higher drug concentra-
tions.
In the experiment described in Fig. 1, radio-
uridine was administered continuously from the
beginning of the AMD exposure period and after
it, and therefore during an interval when no RNA
synthesis was taking place ; however, the uptake of
radiouridine into acid-soluble material ("pool")
was proceeding at a rate unaffected by AMD
(Table I) . This must have resulted in an enlarged
pool of radioactive precursor (i.e. a pool of higher
specific activity) in the AMD treated cells, as com-
pared with the untreated cells . The latter incor-
porate exogenously supplied uridine at a rate
dependent on the concentration in the medium
(within the range of concentrations of uridine used
in our experiments, viz. less than 5 X 10-5 M).
When RNA synthesis of the cells exposed to AMD
began to recover after 3-4 hr of exposure to radio-
uridine, the presence of an enlarged pool of radio-
TABLE I
Recovery of RNA Synthesis in Vero after 2 Hr
Exposure to 10 ,ug/ml of AMD
Vero cells (9 X 105 cells/35-mm Petri dish) were
given 10 µg/ml of AMD at 0 hr and at 2 hr the AMD
medium was removed, and the cells were rinsed
with EBSS and refed with fresh drug-free growth
medium ; the cells were refed again at 4 hr. The
untreated control cells were refed at 0 hr. At 0, 2,
4, 6, 12, and 24 hr, duplicate samples were pulse
labeled for 30 min with 0.3 )uCi/ml of uridine-19C
(50.5 mCi/mmole) and the amount of uridine
taken up by the whole cells (the acid-soluble plus
acid-insoluble fractions) and into the acid-insolu-
ble fraction was determined as described in Ma-
terials and Methods. After refeeding the control
cells there is a decrease in the amount of uridine
taken up by the cells which results in a decreased
rate of incorporation of label into acid-insoluble
material 2 hr after refeeding ; this does not occur in
the presence of AMD .
active nucleoside gave the appearance of a normal,
or faster than normal, rate of RNA synthesis as
compared to untreated cells . The pulse labeling
experiments illustrated in Table I show that, in
Vero, RNA synthesis does not, in fact, fully re-
cover until 18-24 hr after removal of a dose of 10
µg/ml for 2 hr. Restoration of RNA synthesis in L
cells is much slower than in Vero even though L
cells were exposed to a lower dose of AMD . Pulse
labeling experiments show that after treatment for
I hr with 5 µg/ml, L cells do not recover RNA
synthesis until more than 48 hr after removal of the
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uridine-14C uridine-74C corres-
Hours after adding AMD taken up incorporated ponding
or refeeding controls by 106 cells by 106 cells control
µµmoles l .4t1moles %
Untreated control
cells
0 1297 280 100
2 890 163 100
4 1390 208 100
6 1340 219 100
12 1340 298 100
24 1030 252 100
10 µg/ml of AMD
for 2 hr
2 1390 3 <2
4 1500 19 9
6 1577 85 39
12 1600 198 66
24 1500 279 111drug (Fig. 8B). By 12 hr after removal of this dose,
RNA synthesis in L cells is still less than 20% of
that of the untreated control cells. Note also in
Table I that the uptake of uridine 14C is not im-
paired or altered by AMD treatment . The transi-
tory decrease in the uptake of uridine from the
medium shown in control Vero cells in Table I at
2 hr after refeeding with fresh medium is note-
worthy. We have no explanation for this phenom-
enon; it occurs regularly and reproducibly in
Vero and WI-38, but does not occur in HeLa or L
cells.
Dose Response of Inhibition of RNA
Synthesis in Relation to Binding of AMD
The dependency of the rate of radiouridine in-
corporation into RNA upon concentration of
AMD in HeLa, Vero, and L cells is illustrated in
Fig. 2, from which it is apparent that RNA synthe-
sis in HeLa is inhibited at lower concentrations of
AMD than in Vero or L cells . This can be cor-
related with the higher uptake of AMD, at any
given concentration, in HeLa than in Vero or L
cells, as shown in Fig . 3. HeLa bind more than
twice as much AMD-14C during a 1 hr exposure
than Vero or L cells, both on a per cell basis (Fig .
3A) and on a per DNA basis (Fig. 3B). However,
although L cells take up more drug per cell at a
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FIGURE 2 Concentration dependent inhibition of RNA synthesis by AMD . Replicate cultures of Vero,
HeLa, and L cells in 35-mm Petri dishes were given 1 ml of uridine- 14C (0.2 µCi/ml; 50.5 mCi/mmole),
and 15 min later 1 ml of 0.004, 0.02, 0.1, 0.4, 2.0, or 10 µg/ml of AMD was added. 1 and 2 hr after adding
AMD, duplicate samples were prepared for liquid scintillation spectrometry as described in Materials
and Methods. The amount of radioactivity present in the 1 hr acid-insoluble precipitates was subtracted
from the amount in the corresponding 2 hr sample to give the amount of uridine-14C incorporated between
1 and 2 hr after the addition of varying concentrations of AMD . The labeled uridine was added 15 min
before the AMD in order to label the rapidly metabolized RNA, and thereby ensure that all of the nu-
cleotide pools, including those derived from degraded, or metabolized, RNA, were labeled at the time
the drug was added. The results are expressed as the present inhibition of uridine- 14C incorporated by
untreated control cells . o, Vero; A, L ; and o, Hela.
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given concentration than do Vero (Fig . 3A), both
Vero and L take up approximately the same
amount of drug on a DNA basis (Fig. 3B). Fig. 3
also illustrates that, in the range of concentrations
of AMD generally employed to block transcrip-
tion, i.e. less than 20 µg/ml, the amount of drug
taken up by all cell lines is similarly dependent on
the concentration in the medium. Thus, there is a
direct correlation between the extent of inhibition
of RNA synthesis effected by a given concentration
of AMD and the amount of AMD taken up per
unit DNA in all of these cell types. However, Vero
can be made to bind more AMD than HeLa and L
cells but they nevertheless recover RNA synthesis
more rapidly after removal of these higher drug
doses.
Dose Response of Recovery of RNA
Synthesis in Relation to Retention of AMD
Fig. 4A shows that RNA synthesis in Vero re-
covers progressively more slowly after removal of a
given concentration (10 µg/ml) of AMD after
increasingly longer exposure periods, i .e. 2, 4, or 6
hr. Fig. 5 shows that during continuous exposure to
AMD14C, the amount of drug taken up by Vero
reaches an equilibrium after about 2 hr at higher
drug concentrations (5-20 jug/ml) and after about
I hr at lower concentrations (I and 2 .5 Ag/ml) .
10 5.0M
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FIGURE 3 Concentration dependent uptake of AMD-f4C. Replicate cultures of Vero, HeLa, and L cells
were exposed for 1 hr to 1, 2.5, 5, 10, and 20 µg/ml of 14C-labeled AMD (3.8 mCi/mmole, or 3 X 10-3 µCi/
µg), and the amount of radioactivity taken up by the cells was determined as described in Materials and
Methods. Fig. 3A expresses the results as cpm of AMD-14C per 10 5 cells; and Fig. 3B as molecules of
AMD per picogram of DNA. C, Vero 12.6 µg DNA/10 6 cells; V, L, 21 .0 Ag DNA/10 6 cells; and o,
HeLa, 18.2 µg DNA /10' cells.
Therefore, treatment of Vero with AMD for
periods longer than 2 hr does not result in an in-
crease in the ratio of AMD to DNA in the cell .
Vero are unique in this regard compared with
HeLa and L cells because HeLa and L continue to
take up AMD with longer exposure. Although the
rate of uptake of drug in HeLa and L slows after
an initial period of rapid binding in contrast to
Vero, it does not reach an equilibrium (1) . This
equilibrium signifies that after 2 hr the rate of drug
ingress and binding in Vero equals the rate of drug
detachment and excretion ; in HeLa and L cells,
however, the rate of uptake and binding is always
greater than the rate of drug dissociation and
elimination.
Fig. 6 depicts the rate of excretion of AMD 14C
from HeLa, L, and Vero cells. Two main points
are made by these data : (a) Vero eliminate AMD
approximately twice as fast after removal of the
drug as HeLa and L cells ; (b) the rate at which
Vero eliminate AMD is independent of the drug
concentration, and of the length of exposure to the
drug. Thus, the more rapid recovery of RNA syn-
thesis by Vero as compared with L cells after re-
moval of AMD can be correlated with the faster
elimination of the drug by Vero. However, this is
by no means the only determinant of recovery.
RNA synthesis in Vero comes back more quickly
after removal of a given concentration of AMD
B
20
after shorter exposure periods even though no more
AMI) is bound or retained with longer exposure.
Furthermore, Vero recover their RNA synthesis
much more rapidly after removal of 10 µg/ml
applied for 6 hr than do L cells treated for only I
hr with 5 µg/ml. Since Vero take up about four
times as much AMD when treated for 6 hr with 10
µg/ml than do L cells treated for 1 hr with 5 µg/
ml, and because Vero eliminate the drug only
about twice as rapidly, it would be expected, if
recovery of RNA synthesis were due solely to elimi-
nation of AMD, that L cells should be able to
recover RNA synthesis after this dose (5 µg/ml) to
about the same extent and at approximately the
same time as Vero. This is clearly not the case as is
apparent in Fig. 1 .
It appears from Fig. 4B that the rate of recovery
of RNA synthesis is relatively independent of the
drug concentration within the range from 0 .5 to
10 pg/ml. RNA synthesis is depressed propor-
tional to dose up to 2 .5 µg/ml; at concentrations
higher than 2.5 pg/ml, RNA synthesis is maxi-
mally inhibited, notwithstanding that more AMD
continues to be bound at concentrations higher
than this (Figs. 3 and 5). After withdrawal of
AMI) after an exposure period of 2 hr, the rate of
restoration of RNA synthesis is independent of
drug concentration, once the level of intracellular
AMI) has diminished below that necessary to
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inhibit RNA synthesis maximally. Thus, after
removal of 10 µg/ml after 2 hr, RNA synthesis
remains suppressed for an additional 2 hr before
recovery begins; but RNA synthesis begins to come
back immediately after removal of 2.5 µg/ml or
lesser concentrations . If the apparent rates of RNA
synthesis are compared at a fixed time, e .g. at 12 hr
after treatment of Vero for 2 hr with 0.5, 1, 2.5,
and 10 µg/ml of AMD, recovery appears not to
follow in strict concentration-dependent fashion .
After exposure to the lower drug concentrations
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FIGURE 4 Dependence of recovery of RNA synthesis on AMD dose . Fig. 4A, Dependence of the rate
of recovery of RNA synthesis on the length of the drug exposure period . Vero cells growing in 35-mm
Petri dishes (1 .5 X 106 cells/dish) were treated for 2 (0), 4 (0), or 6 (o) hr with 10 jug/ml of AMD,
after which times the drug was removed and the cells were rinsed and refed ; the cells were refed again
3 hr later . At 0, 3, 6, 12, and 22 hr after removal of the drug, duplicate dishes were pulse labeled for
30 min with uridine- 14C (0.2 µCi/ml, 4 µM uridine) and the amount of radioactivity associated with
the acid-insoluble precipitates of a known number of cells was determined as described in Materials
and Methods. The rate of incorporation of uridine- 14C into acid-insoluble material was corrected for
changes in the rate of uptake of uridine . The rate of incorporation of uridine-'4C in untreated control
cells was 204 µµmoles/10 6 cells/30 min. Therefore, in this experiment, the rate of uridine incorporation
had not returned to the control rate of 24 hr after removal of a 2 hr pulse dose of 10 µg/ml, but was at
75-807 in contrast to the experiment reported in Table I in which the rate of uridine incorporation 24
hr after removal of the same dose of AMD slightly exceeded the control value . The cell density of the
monolayer in this experiment was approximately twice that of the experiment reported in Table I . Fig.
4B. Dependence on drug concentration of the rate of restoration of uridine- 14C incorporation. Vero
cells (1.25 X 10 6 cells/35-mm Petri dish) were treated with 0 .5 Ag/ml (V) ; 1.0 µg/ml (O) ; 2.5 µg/ml
(o) ; and 10 Ag/ml (0) of AMD . After 2 hr the AMD was removed, the cells were rinsed and refed with
drug-free medium; the cells were refed again 3 hr after removing the AMD . Immediately after removing
the AMD, and 3, 6, 12, and 24 hr later, duplicate samples were pulsed for 30 min with uridine- 14C (0.3
µCi/ml; 58 mCi/mole) and the amount of label taken up by the cells and the amount incorporated
into the acid-insoluble fraction was determined as described in Materials and Methods . Since, 3 hr after
feeding, control Vero cells take up 50% less uridine (and therefore incorporate 500 110 less uridine into
acid-insoluble material) than cells fed 12 hr before or cells treated with AMD (see Table I), the rate
of uridine incorporation used as the control (100% = 305 µµmoles/10 6 cells/30 min) was the 0 hr value
which was obtained from cells fed 12 hr before the beginning of the experiment .
(less than 2.5 µg/ml), the over-all rate of uridine
incorporation returns to the control level within 12
hr, but after treatment with 10 µg/ml restoration
of RNA synthesis is delayed until 20-24 hr .
Fig. 7 shows that after treatment for 12 hr with
I jug/ml, a dose that quickly reduces uridine in-
corporation to less than 10 % of untreated cells,
Vero rapidly recover, and by 24 hr after drug re-
moval RNA synthesis is near the rate of untreated
cells. However, after removal of 5 and 10 µg/ml
applied for 12 hr, recovery of RNA synthesis is100
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FIGURE 6 Rate of release of AMD- 14C 1-lela (O) and
L (V) cells were treated with 2.5 Ag/ml of AMD-14C
for 1 hr, and Vero with 2.5 µg/ml for 1 hr (®), or 10
µg/ml for 1 hr (0), 4 hr (U), or 12 hr (®) . The medium
containing AMD-14C was then removed (0 time) and
the cells were rinsed three times and refed with drug-
free medium. At the times indicated on the abscissa,
the amount of radioactivity associated with the cells
was determined as described in Materials and Methods .
slower, and its rate is independent of concentra-
tion ; 24 hr after removal of 10 µg/ml for 12 hr, it is
at the same level as after removal of 5,ug/ml for 12
hr, i.e. approximately 65% of that of the untreated
control cells. We have observed that RNA synthe-
sis is more readily reinstated in all types of cells
after prolonged treatment with concentrations of
AMD that do not completely suppress RNA syn-
thesis, although uridine incorporation may be only
0
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FIGURE 5 Uptake of AMD-14C with time by Vero.
Vero cells were exposed to 1, 2.5, 5, 10, and 20 µg/ml of
AMD-14C (3 X 10-3 µCi/µg) continuously, and at
hourly intervals the amount of radioactivity taken up
by the cells was determined as described in Materials
and Methods. An equilibrium or steady state is at-
tained by 2 hr at every concentration.
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FIGURE 7 Recovery of RNA synthesis in Vero after
12 hr of exposure to 1, 5, and 10 µg/ml of AMD . Vero
cells were exposed to 1, 5, and 10 µg/ml of AMD for
12 hr, after which the cells were rinsed and refed with
drug-free medium ; the cells were refed again 4 and 12
hr later. At 0, 3, 12, and 24 hr after removing the
AMD, duplicate cultures were pulse labeled for 30 min
with uridine- 14C (0.1 µCi/ml, 50.5 mCi/mmole) and
the incorporation into acid-insoluble material was
determined as described in Materials and Methods.
The results are expressed as per cent of control (100% =
83 )Uµmoles/106 cells). 1 µg/ml, open; 5 µg/ml, striped;
and 10 µg/ml, closed .
5-157 of the normal value . Apparently, the effect
of AMD is more reversible if transcription had not
been altogether extinguished during treatment.
Over-all Protein Synthesis and
Cell Division
Since, after treatment with AMD, Vero re-
covered the capacity to incorporate radiolabeled
uridine much more quickly than L cells, we in-
quired whether restoration of the capacity to
incorporate amino acids was linked to recovery of
RNA synthesis and was therefore restored more
quickly in Vero than in L cells . Figs. 8A and 8B
show that incorporation of amino acids14C in L
appears to be more sensitive to AMD than in Vero
cells : 4-8 hr after treatment with suppressive con-
centrations, it declines to approximately 25 % in L
and 507 0 in Vero of the value of untreated cells .
However, after 24 hr the rate of incorporation of
amino acids returns to about the same level (60 00
of untreated cells) in both cell types. Although
over-all RNA synthesis remains suppressed after
removal of AMD for substantially longer times in
L than in Vero cells, over-all incorporation of
amino acid in L cells nevertheless returns to the
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FIGURE 8 Recovery of RNA and protein syntheses in Vero and L cells . Vero (8A) and L(8B) cells were
treated with 10 µg/ml of AMD for 2 hr and 5 µg/ml for 1 hr, respectively, after which times the AMD
was removed, and the cells were rinsed with EBSS and refed again 4 hr later. At the intervals indicated
on the graph, after beginning the treatment with AMD, duplicate dishes were pulse labeled for 30 min
with 0.3 µCi/ml of uridine-14C (50.5 mCi/mmole) (V) or 1 µCi/ml of amino acids- 14C (0.1 mCi/0.067 mg)
(O), and the amount of radioactivity taken up and incorporated by a known number of viable cells, i .e.
cells excluding trypsin blue, was measured as described in Materials and Methods . Untreated Vero and
L cells incorporated 1 .98 X 105 dpm and 1 .09 X 105 dpm per 106 cells, respectively, of amino acids-14C,
and 304 and 294 µµmoles of uridine per 106 cells, respectively .
TABLE II
Recovery of Cell Division
Vero and L cells were exposed to the various doses of AMD as indicated in the table,
and the cells were fixed at 12 hr intervals after the beginning of the drug treatment .
The mitotic figures present per 1000 viable cells were determined by microscopic
examination. The drug was administered at 0 hr and removed at the time indicated
under dosage.
same level as in Vero after 24 hr. The greater ini-
tial sensitivity of amino acid incorporation in
L cells to AMD could reflect either a direct in-
fluence of the drug on protein synthesis (5, 6) or a
faster turnover of message RNA in L cells com-
pared to Vero, and/or a more rapid disappearance
of acid-precipitable aminoacyl tRNA . A direct
effect on protein synthesis (at least in Vero)
appears unlikely since Vero were treated with a
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B L(51Jg/ml forlhr)
higher dose of AMD, and consequently three to
four times more AMD was taken up per Vero cell
than per L cell. It might therefore be expected
that, if protein synthesis were directly inhibited by
AMD, the Vero cells would have been more in-
fluenced than the L cells. But, in fact, recovery of
protein synthesis after AMD more closely parallels
recovery of RNA synthesis in L than in Vero cells .
Vero do not recover their capacity for cull divi-
Mitoses per 1000 cells after treatment with AMD
Cell type Dosage of AMD 0 hr 12 hr 24 hr 36 hr 48 hr 60 hr 72 hr
Vero 10
	
µg/ml for 2 hr 31 0 0 0 0 20 17
5
	
µg/ml for 1 hr 37 0 1 1 1 19 36
2 .5 µg/ml for 2 hr 36 0 0 0 15 14 28
1
	
Ag/ml for 2 hr 39 1 1 3 24 31
0 .5 µg/ml for 2 hr 42 7 10 15 41
0 .25 µg/ml for 9 hr 29 1 7 19 20
L 5
	
µg/ml for I hr 32 0 14 8 15 34sion any faster after exposure for 1 hr to 5 ,ug/ml of
AMD than do L cells treated with the same dose
(Table II) . Table II illustrates the "division-
delay", i.e. the lag in resumption of mitosis, which
occurs after exposure to varying concentrations of
AMD. At concentrations higher than 1 µg/ml,
there is no cell division between 12 and 36 hr. In
Vero, beginning after 36-48 hr, mitoses gradually
begin to appear until by 3 days there is a near
normal mitotic index . However, exposure of Vero
to concentrations less than 1 µg/ml for periods up
to 9 hr results in a short delay in cell division, even
though RNA synthesis has been reduced to less
than 20% of that of the control. The length of the
period of division-delay after removal of pulse
doses of AMD is, therefore, dependent on concen-
tration only at those concentrations that suppress
transcription less than completely. At concentra-
tions greater than I µg/ml, which inhibit RNA
synthesis by more than 90%, the length of the
interval before recovery of cell division is independ-
ent of concentration. For Vero this is 2-3 days, and
for L cells it is 1-2 days . These data suggest that
the apparent quicker recovery of over-all RNA
synthesis in Vero as compared to L cells is merely
quantitative, but that qualitative recovery, as
judged by the restoration of apparent protein syn-
thesis and cell division, takes much longer.
DISCUSSION
As we (1, 2) and others (3, 4) have noted, Vero
cells can recover their capacity to incorporate
radiolabeled uridine much faster than most other
cell types after removal of inhibiting concentrations
of AMD. This occurs at doses even exceeding those
that fully suppress transcription. The mechanism
responsible for the rapid detachment and elimina-
tion of AMD by Vero, as compared with HeLa or
L cells is unknown . However, the rapid recovery of
over-all RNA synthesis in Vero can only partly be
explained by the remarkable capacity of these cells
to eliminate bound AMD . It appears that cells
derived from kidney of the African green monkey
(Cercopithecus) have the capacity to recover RNA
synthesis rapidly after its suppression by AMD, and
are also relatively resistant to the toxicity of AMD
(1, 2, 3, 7). Their resistance to cell injury is not due
solely to their smaller uptake or more rapid release
of AMD (1) . Even when Vero cells are forced to
bind more AMD than L and HeLa cells, they can
nevertheless eliminate the drug, and restore RNA
synthesis rapidly. Therefore, the relative resistance
of Vero to AMD is not due to any diminished
capacity of these cells to bind AMD, nor does it
result from metabolic inactivation of the drug by
the Vero cell. We have observed that the AMD
eliminated from Vero after having been bound can
inhibit RNA synthesis in HeLa cells (unpublished
observation) . Voll and Leive (8) have isolated a
mutant Escherichia coli which also eliminates bound
AMD, recovers RNA synthesis more rapidly, and
is more resistant to the lethal effects of AMD than
its parent. The AMD is eliminated in a form in-
distinguishable by chromatography from authentic
AMD. Schwartz et al. (9) have also reported that
the AMD eliminated from liver tissue is un-
changed. Whatever the mechanism that enables
Vero to eliminate AMD so rapidly, it is not related
to metabolic alteration of the AMD .
Although Vero are more proficient in excreting
the bound drug, elimination of AMD is by no
means the only important factor governing re-
covery of RNA synthesis after it has been sup-
pressed by the drug, and, although removal of the
drug from DNA is a precondition of recovery of
transcription, it is not a sufficient condition . The
capacity of Vero cells to incorporate labeled uri-
dine is restored proportionately more slowly after
removal of a given concentration of AMD after
progressively longer exposure periods (Fig . 4A),
even though periods of exposure longer than 2 hr
do not result in a further increase in the amount of
AMD in the cell (Fig. 5), and notwithstanding that
the rate of drug elimination is independent of the
length of exposure (Fig. 6). Furthermore, Vero
cells, although exposed to ten times or more the
concentration of AMD than L cells (with pro-
portionately greater uptake by the Vero), still
recover RNA synthesis much more rapidly than do
L cells treated with lower doses. The binding of
AMD to cells is clearly a reversible process (1, 9,
10, 11), but the effect of the drug on transcription
is of considerably longer duration than would be
expected from the length of the period of retention
of the drug. Therefore, recovery of transcription
must depend on other factors in addition to the
release of AMD from the cell. Although Vero cells
eliminate AMD rapidly and restore over-all RNA
synthesis within a few hours after the removal of
concentrations sufficient to inhibit transcription by
more than 90%, a stationary period of 2-3 days
ensues during which very few or no mitoses occur,
but after which cell division resumes . This phe-
nomenon of division-delay is observed in both
Vero and L cells; however, L cells, which cannot
instaurate over-all RNA synthesis as rapidly as
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promptly than Vero. It is of interest that the
mutant E. coli described by Voll and Leive (8),
which could eliminate AMD and restore tran-
scription rapidly, apparently also suffered a period
of division-delay. During the interval of division-
delay and resurgent RNA synthesis after AMD,
there is a parallel failure of premitotic semicon-
servative DNA synthesis (data to be published) .
After cessation of transcription the cells are stopped
from progressing in the division cycle . Present
evidence (see 12, 13) supports the concept that
some species of RNA, which are rapidly lost after
abolition of RNA synthesis, are required for nu-
clear activation leading to division . Production of
these species of RNA is relatively resistant to AMD,
because pulse exposure to high concentrations is
required to induce more than transient division
in Vero.
If RNA synthesis in Vero is blocked less than
completely, i.e. by exposure to concentration of
AMD less than I ug/ml, a shorter period of divi-
sion-delay ensues than when transcription is fully
suppressed at concentrations greater than 1 µg/ml .
Concentrations in excess of those that extinguish
RNA synthesis do not cause a concentration-
dependent lengthening of division-delay. It would
appear, therefore, that resynthesis of certain
species of RNA, transcription of which is inhibited
only by high doses of AMD, is required for cells to
reenter the division cycle after suppression by
AMD. Cell division is almost immediately restored
after removal of low concentrations of AMD in
contrast to the effects of high concentrations, which
produce a long period of division-delay. We pro-
pose that RNA species, synthesis of which is rela-
tively resistant to extinction by AMD, are involved
either directly (14) or indirectly (15, 16) in the
activation of genes controlling progression of the
cell cycle and cell division . It is postulated that
these RNA species continue to be synthesized
during treatment with low, but not high, concen-
trations of AMD, and therefore those genes whose
products are required for cell division are reacti-
vated immediately after removing low drug con-
centrations. After relief of inhibition by high con-
centrations, however, the prolonged period of
division-delay that ensues is at least partly attribut-
able to the time required for resynthesis of RNAs
necessary for the reactivation of genes whose prod-
ucts in turn govern the reentry of the cells into the
division cycle. The fact that Vero treated for 2 hr
with 2.5µg/ml suffer a lag in cell division of 2 days
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after over-all uridine incorporation into RNA has
returned to the control level, suggests that restora-
tion of the qualitatively correct RNA-dependent
sequence of steps in gene activation (13), rather
than the over-all rate of RNA synthesis, determines
when the cells will reenter the division cycle after
treatment with AMD, In this regard, Schlueder-
berg and her colleagues (3) have reported that
after removal of high concentrations of AMD from
Vero a normal cytoplasmic profile of the major
classes of labeled RNA does not reappear until
after 48 hr. This finding and our data on resump-
tion of protein synthesis indicate that while the
over-all rate of RNA synthesis has come back to a
normal level within 24 hr, the spectrum of RNAs
synthesized is qualitatively abnormal or un-
balanced.
It is a reasonable hypothesis that reinitiation of
RNA synthesis after its suppression requires the
operation of certain cytoplasmic and nuclear
"factors", among them probably certain proteins
of the class of the acidic chromosomal protein
(13, 16). After the suppression of RNA synthesis
these factors and their templates must be presumed
to decay at variable rates, the rate depending on
the cell type. Suppression of transcription for a
sufficient time may eventuate in a state of nuclear
repression similar to that, for example, of the
nucleated avian erythrocyte in which the nucleus,
although inactive, is capable of being reactivated
by fusion with an active proliferating cell such as
HeLa (17) . The reactivation of chick-erythrocyte
nuclei in heterokaryons composed of erythrocyte
nuclei and HeLa cells is thought to be triggered by
the migration of proteins from the HeLa cytoplasm
into the erythrocyte nucleus (18) . This is one
among many examples and experiments demon-
strating that factors (presumably proteins) fabri-
cated or present in the cytoplasm control the ac-
tivity of the nucleus (19, 20, 21) ; and the renewal
of these depends in turn upon RNA synthesis. The
reactivation of RNA synthesis after elimination of
AMD from animal cells may, therefore, depend
upon the stability of such factors, i.e. proteins or
their templates, necessary for the initiation of
transcription; and as these factors decay, during
inhibition by AMD, faster in some cell types than
others, the rate at which transcription recovers will
progressively diminish . This hypothesis will be the
subject of experiments to be reported later .
Actinomycin D, an antibiotic whose primary
effect on cells has been so amply elucidated, can
be a valuable probe for examining the processes ofgene reactivation after suppression of transcription,
especially in Vero cells, because these cells are rela-
tively resistant to the cytotoxicity of this agent .
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